15.20
-0.02
(-0.13%)
At close: January 21 at 4:00:02 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2011) | Next Qtr. (Jun 2011) | Current Year (2011) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0 | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2011) | Next Qtr. (Jun 2011) | Current Year (2011) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 3/31/2010 |
|---|---|
| EPS Est. | -- |
| EPS Actual | -0 |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2011) | Next Qtr. (Jun 2011) | Current Year (2011) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2011) | Next Qtr. (Jun 2011) | Current Year (2011) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FONR | -- | -- | -- | -- |
| S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Related Tickers
TMOS34.SA Thermo Fisher Scientific Inc.
71.52
+1.17%
TN8.DE Thermo Fisher Scientific Inc.
548.80
+2.33%
DIAS.VI DiaSorin S.p.A.
103.95
+2.87%
VIMIAN.ST Vimian Group AB (publ)
40.35
+1.25%
8YY.SI Biolidics Limited
0.0280
+3.70%
MVF.AX Monash IVF Group Limited
1.2070
+1.00%
STRR Star Equity Holdings, Inc.
2.2100
-5.56%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%
CBAV.MC Clínica Baviera, S.A.
32.50
0.00%
CHHL China Holdings, Inc.
0.0002
0.00%